Abstract
The aim of this study was to investigate the effect of a rotigotine transdermal patch on stationary and non-stationary locomotion in de novo Parkinson disease (PD) patients in an open-label uncontrolled study. A 3-D gait analysis system was used to investigate four different locomotor tasks: steady-state linear walking, gait initiation, gait termination and 180°-turning. A series of gait variables were measured for each locomotor task. PD patients who received rotigotine treatment (4–8 mg) displayed: (1) increased step length, gait speed, cadence and arm oscillations, and reduced double support duration and step asymmetry during steady-state linear gait; (2) increased initial step length during gait initiation; (3) increased final step length and gait speed, and decreased stability index during gait termination; (4) decreased duration of turning and head–pelvis delays during 180°-turning. The main finding that emerges from the present study is that the dopamine agonist rotigotine can improve various aspects of gait in de novo PD patients.
Similar content being viewed by others
Abbreviations
- PD:
-
Parkinson disease
- DA:
-
Dopamine antagonists
- CoP:
-
Center of pressure
- CoM:
-
Center of mass
- GI:
-
Gait initiation
- GT:
-
Gait termination
References
Vieregge P, Stolze H, Klein C, Heberlein I (1997) Gait quantitation in Parkinson’s disease—locomotor disability and correlation to clinical rating scales. J Neural Transm 104:237–248
Morris M, Iansek R, McGinley J, Matyas T, Huxham F (2005) Three-dimensional gait biomechanics in Parkinson’s disease: evidence for a centrally mediated amplitude regulation disorder. Mov Disord 20:40–50
Sofuwa O, Nieuwboer A, Desloovere K, Willems AM, Chavret F, Jonkers I (2005) Quantitative gait analysis in Parkinson’s disease: comparison with a healthy control group. Arch Phys Med Rehabil 86:1007–1013
Boonstra TA, van der Kooij H, Munneke M, Bloem BR (2008) Gait disorders and balance disturbances in Parkinson’s disease: clinical update and pathophysiology. Curr Opin Neurol 21:461–471
Elble RJ, Cousins R, Leffler K, Hughes L (1996) Gait initiation by patients with lower-half parkinsonism. Brain 119:1705–1716
Carpinella I, Crenna P, Calabrese E, Rabuffetti M, Mazzoleni P, Nemni R, Ferrarin M (2007) Locomotor function in the early stage of Parkinson’s disease. IEEE Trans Neural Syst Rehabil Eng 15:543–551
Cameron D, Murphy A, Morris ME, Raghav S, Iansek R (2010) Planned stopping in people with Parkinson. Parkinsonism Relat Disord 16:191–196
Willems AM, Nieuwboer A, Chavret F, Desloovere K, Dom R, Rochester L, Kwakkel G, van Wegen E, Jones D (2007) Turning in Parkinson’s disease patients and controls: the effect of auditory cues. Mov Disord 22:1871–1878
Schapira AH, Emre M, Jenner P, Poewe W (2009) Levodopa in the treatment of Parkinson’s disease. Eur J Neurol 16:982–989
Jankovic J, Poewe W (2012) Therapies in Parkinson’s disease. Curr Opin Neurol 25:433–447
Jenner P (2005) A novel dopamine agonist for the transdermal treatment of Parkinson’s disease. Neurology 65:S3–S5
Fasano A, Guidubaldi A, De Nigris F, Bentivoglio AR (2011) Safety and efficacy of rotigotine in individuals with Parkinson’s disease aged 75 and older. J Am Geriatr Soc 59:2386–2387
Zhou CQ, Li SS, Chen ZM, Li FQ, Lei P, Peng GG (2013) Rotigotine transdermal patch in Parkinson’s disease: a systematic review and meta-analysis. PLoS One 8:e69738
Baltadjieva R, Giladi N, Gruendlinger L, Peretz C, Hausdorff JM (2006) Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson’s disease. Eur J Neurosci 24:1815–1820
Wren TA, Gorton GE 3rd, Ounpuu S, Tucker CA (2011) Efficacy of clinical gait analysis: a systematic review. Gait Posture 34:149–153
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
Wu G, Siegler S, Allard P, Kirtley C, Leardini A, Rosenbaum D, Whittle M, D’Lima DD, Cristofolini L, Witte H, Schmid O, Stokes I (2002) Standardization and Terminology Committee of the International Society of Biomechanics. ISB recommendation on definitions of joint coordinate system of various joints for the reporting of human joint motion–part I: ankle, hip, and spine. J Biomech 35:543–548
Davis RB, Ounpuu S, Tyburski D, Gage JR (1991) A gait analysis data collection and reduction technique. Hum Mov Sci 10:575–587
Gutierrez-Farewik EM, Bartonek A, Saraste H (2006) Comparison and evaluation of two common methods to measure center of mass displacement in three dimensions during gait. Hum Movement Sci 25:238–256
Serrao M, Pierelli F, Ranavolo A, Draicchio F, Conte C, Don R, Di Fabio R, LeRose M, Padua L, Sandrini G, Casali C (2012) Gait pattern in inherited cerebellar ataxias. Cerebellum 11:194–211
Serrao M, Mari S, Conte C, Ranavolo A, Casali C, Draicchio F, Di Fabio R, Bartolo M, Monamì S, Padua L, Pierelli F (2013) Strategies adopted by cerebellar ataxia patients to perform U-turns. Cerebellum 12:460–468
Serrao M, Conte C, Casali C, Ranavolo A, Mari S, Di Fabio R, Perrotta A, Coppola G, Padua L, Monamì S, Sandrini G, Pierelli F (2013) Sudden stopping in patients with cerebellar ataxia. Cerebellum 12:607–616
Conte C, Serrao M, Casali C, Ranavolo A, Silvia M, Draicchio F, Di Fabio R, Monami S, Padua L, Iavicoli S, Sandrini G, Pierelli F (2012) Planned gait termination in cerebellar ataxias. Cerebellum 11:896–904
Winter DA, Mc Fayden BJ, Dickey JP (1991) Adaptability of the CNS in human walking. Adv Psychol 78:127–144
Hass CJ, Waddell DE, Wolf SL, Juncos JL, Gregor RJ (2008) Gait initiation in older adults with postural instability. Clin Biomech 23:743–753
Studenski S, Perera S, Wallace D, Chandler JM, Duncan PW, Rooney E et al (2003) Physical performance measures in a clinical setting. J Am Geriatr Soc 51:314–322
Ricciardi L, Bloem BR, Snijders AH, Daniele A, Quaranta D, Bentivoglio AR, Fasano A (2014) Freezing of gait in Parkinson’s disease: the paradoxical interplay between gait and cognition. Parkinsonism Relat Disord 20:824–829
Hase K, Stein RB (1998) Analysis of rapid stopping during human walking. J Neurophysiol 80:255–261
Crenna P, Carpinella I, Rabuffetti M, Calabrese E, Mazzoleni P, Nemni R, Ferrarin M (2007) The association between impaired turning and normal straight walking in Parkinson’s disease. Gait Posture 26:172–178
Huxham F, Baker R, Morris ME, Iansek R (2008) Head and trunk rotation during walking turns in Parkinson’s disease. Mov Disord 23:1391–1397
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
We report the following consultancy for Alfonso Fasano, Stock Ownership in medically-related fields: none; Consultancies: UCB pharma, Medtronic, Boston Scientific, Abbvie; Advisory Boards: Abbvie; Partnerships: none; Honoraria: UCB pharma, Medtronic, Boston Scientific, Abbvie; Grants: University of Toronto, Michael J. Fox Foundation; Intellectual Property Rights: none; Expert Testimony: none; Employment: none; Contracts: none; Royalties: none; Other: none; The other authors declare any financial or other relationships that might lead to a conflict of interest.
The other authors declare any financial or other relationships that might lead to a conflict of interest.
Ethical standard
Informed consent was obtained from all the participants in the study, which was approved by the local institutional review board. All experimental procedures were in accord with the Declaration of Helsinki.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Serrao, M., Ranavolo, A., Conte, C. et al. Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study. J Neurol 262, 2539–2547 (2015). https://doi.org/10.1007/s00415-015-7883-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-015-7883-4